To mark International Women’s Day we recently spoke with Victoria Sanz Moreno from Kings College London (UK) to find out what inspired her to get into cancer research.
Browsing: tumor biology
Investigators have discovered why Huntington’s disease is so toxic to cancer cells and are harnessing it as a novel approach to treat cancer.
A PGE2-receptor type-4 inhibitor, termed E7046, has demonstrated promising clinical activity in a Phase I trial of patients with advanced solid tumors.
To mark World Cancer Day we are highlighting the most significant advancements in modern oncology to investigate how the field has advanced and what hurdles still need to be overcome.
A novel viral-gene therapy could improve results from breast reconstruction surgery after cancer treatment by helping healthy tissue protect itself from radiotherapy damage.
Researchers have discovered that anti-PD-1/PD-L1 therapies are highly effective in patients with desmoplastic melanoma, challenging previous assumptions.
Find out about the characteristics of patient-derived xenograft models and their application for basic & preclinical cancer research in this editorial from Future Science OA.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.
A team of researchers have reported T cells survive a tumor’s anoxic environment and become more effective at killing cancer cells by exploiting HIF-1a and when they have access to growth factor VEGF-A.